A PK Study Comparing MB05, EU-sourced Synagis® and US-sourced Synagis® in Healthy Volunteers.
Clinical trial NCT05121246 · COMPLETED
Trial details
- NCT number
- NCT05121246
- Sponsor
- mAbxience Research S.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2023-03-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.